by Paul Alan Levy This morning I attended a hearing at the D.C. Board of Zoning Adjustment in a case relating to a neighborhood issue in which I have been engaged – an appeal by our local Advisory Neighborhood Commission of the issuance of a building permit that allows Bogdan Builders to “pop-up” a row […]
Category Archives: Uncategorized
by Paul Alan Levy In a decision issued today, the Court of Appeals for the Federal Circuit sitting en banc overruled a 1981 ruling by the U.S. Court of Customs and Patent Appeals and held that the portion of section 2(a) of the Lanham Act that forbids the Trademark Office from registering disparaging trademarks is […]
…..is the title of a New York Times article discussing how debt collectors use the courts to sue, but bar a subsequent suit by the debtor (or alleged debtor) based on an arbitration clause in the debtor’s original contract with the creditor. The article discusses several cases where individuals who either didn’t know about the […]
We told you in May that Public Citizen was representing Prof. Rebecca Tushnet of Georgetown Law in seeking to intervene and unseal court documents in a trademark dispute between Amazon.com and the maker of a dietary supplement called SeroVital. The district court denied summary judgment to Amazon this past spring, but key facts on which the […]
…is the subject of a recent article from FiveThirtyEight, which explains how the middle class has shrunk over the past 45 years and where those formerly in the middle class have gone (economically speaking). And where have they gone? More Americans are now either at the extremes of wealth or poverty than in the middle (defined as […]
The Wall Street Journal reports today on the enforcement actions taken yesterday by the Consumer Financial Protection Bureau and puts them in context of CFPB's upcoming payday lending regulation. The article is here. (Subscription may be required.)
The New York Times explains, with maps.
The controversial Turing Pharmaceuticals CEO was arrested today for wire and securities fraud. The New York Times explains succinctly why Skhreli has become symbolic of what's wrong in the industry: Mr. Shkreli has emerged as a symbol of pharmaceutical greed for acquiring a decades-old drug used to treat an infection that can be devastating for babies […]
The Consumer Financial Protection Bureau today took separate actions against a company and an individual that resold sensitive personal data to lenders and debt collectors, allegedly exposing millions of consumers to harassment and deceit. In a complaint filed in federal court, the CFPB alleged that T3Leads bought and sold personal information from payday and installment […]
The Federal Trade Commission today announced a settlement providing for the largest monetary award ever obtained by the FTC in an order enforcement action: LifeLock will pay $100 million to settle contempt charges that it violated a 2010 federal court order that requires the company to secure consumers’ personal information and prohibits the company from […]